A comparison of polymerase chain reaction and an infectivity assay for human immunodeficiency virus type 1 titration during virus inactivation of blood components
- 1 October 1993
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 33 (10) , 838-841
- https://doi.org/10.1046/j.1537-2995.1993.331094054622.x
Abstract
Three examples of human plasma-derived concentrates, intermediate-purity factors VIII and IX, and fibrinogen were spiked with tissue culture-grown human immunodeficiency virus type 1 (HIV-1) strain RF. All examples were freeze-dried and heated at 80 degrees C for 72 hours by using validated production process models. HIV-1 infectivity was measured by a syncytial infectivity assay in C8166 cells and then compared with levels determined by nested HIV polymerase chain reaction (PCR). The infectivity assay demonstrated a reduction index of at least 4.5 log10, while PCR showed an average 1.7 log10. Large amounts of HIV-1 RNA (10(5)) were still detectable by PCR in samples in which infectivity assays failed to detect any HIV-1. These data suggest that HIV-1 PCR levels do not parallel HIV-1 infectivity levels during virus-inactivation procedures involved in coagulation factor concentrate production. PCR was able to detect the RNA associated with inactivated HIV-1 particles in the factor concentrates, which allows the conclusion that PCR is not a useful test with which to monitor virus-inactivation procedures such as heating at 80 degrees C for 72 hours. This judgment contrasts with the more definite and sensitive role of PCR in diagnosing HIV-1 infection in patients in whom a positive HIV-1 PCR result correlates with active HIV-1 infection and with PCR's usefulness in monitoring virus removal.Keywords
This publication has 27 references indexed in Scilit:
- Resolution of infection status of human immunodeficiency virus (HIV)‐ seroindeterminate donors and high‐risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high‐prevalence areaTransfusion, 1992
- Absence of human immunodeficiency virus (HIV) proviral sequences in seronegative hemophilic men and sexual partners of HIV-seropositive hemophiliacsTransfusion, 1992
- Detection of HIV-1 RNA in factor VIII concentrateAIDS, 1991
- Detection by PCR of hepatitis C virus in factor VIII concentratesThe Lancet, 1990
- Severely Heated Therapeutic Factor VIII Concentrate of High Specific ActivityVox Sanguinis, 1989
- Viral inactivation strategies for monoclonal antibodies: DRY heatingBiotechnology Techniques, 1989
- Thermal Inactivation of Human Immunodeficiency Virus in Lyophilised Blood Products Evaluated by ID50TitrationsVox Sanguinis, 1986
- Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 1985
- A Therapeutic Concentrate of Coagulation Factors II, IX and X from Citrated, Factor VIII‐Depleted PlasmaVox Sanguinis, 1973
- Neues Verfahren zur maßanalytischen Bestimmung des Wassergehaltes von Flüssigkeiten und festen KörpernAngewandte Chemie, 1935